Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 334 participants.

Also called NCT01277822

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 334 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01277822
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01277822. Randomized; double masking; primary purpose treatment. Start 2011-05-30 (actual); primary completion 2013-04-22 (actual). Results posted on 2014-04-24.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)
Condition
Hypertension
Intervention (Drug)
Losartan (+) amlodipine
Intervention (Drug)
Placebo to match losartan/amlodipine tablets
Intervention (Drug)
Amlodipine camsylate
Intervention (Drug)
Placebo to match amlodipine
Lead sponsor
Organon and Co (class: industry)

Record details

Record id
cardio:ct-nct01277822
Content hash
92a1389efc12daad1cfbe1d529b57638aae7d5faae986f85954026b6649c36eb